Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AG Bell International was a nonprofit hearing-health and education organization focused on improving outcomes for people who are deaf or hard of hearing, particularly through listening and spoken language support, family education, and professional training. It appears to have operated as the international arm associated with the Alexander Graham Bell community and expanded outreach in Spanish-speaking populations, especially in Spain and among Spanish speakers in the United States. The entity was incorporated in the United Kingdom in 2007, previously used the name CLAVE - Caring for Hearing Impairment, and was later renamed AG Bell International. Its activities were centered on human health support, education, advocacy, and community programming rather than therapeutic drug development. UK Companies House records indicate the company was dissolved on June 13, 2023.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AG Bell International.